Scilex Holding (SCLXW) Amortization - Intangibles (2022 - 2026)

Scilex Holding (SCLXW) recorded quarterly Amortization - Intangibles of $2.1 million in Q1 2026, up 56.82% quarter-over-quarter from $1.3 million in Q4 2025, and up 108.78% on a YoY basis from $1.0 million in Q1 2025.

Scilex Holding (SCLXW) Amortization - Intangibles (2022 - 2026) Analysis & Trends

Scilex Holding's Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $2.1 million for Q1 2026.

  • In Q1 2026, Amortization - Intangibles rose 108.78% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $5.4 million (up 36.01% YoY), while the FY2025 annual figure was $4.4 million, up 8.26% from the prior year.
  • Amortization - Intangibles was $2.1 million for Q1 2026 at Scilex Holding, up from $1.3 million in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $2.1 million in Q1 2026 to a low of $935000.0 in Q1 2022.
  • Historically, Amortization - Intangibles has averaged $1.1 million across 5 years, with a median of $1.0 million in 2022.
  • The sharpest annual moves came in 2023 and 2026: Amortization - Intangibles declined 2.53% in 2023, then jumped 108.78% in 2026.
  • A 5-year view of Amortization - Intangibles shows it stood at $1.0 million in 2022, then declined by 0.0% to $1000000.0 in 2023, then gained by 0.1% to $1.0 million in 2024, then surged by 33.27% to $1.3 million in 2025, then surged by 56.82% to $2.1 million in 2026.
  • The last three Amortization - Intangibles figures came in at $2.1 million (Q1 2026), $1.3 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Scilex Holding - - 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.09 Mn
Dec 31, 2025 1.33 Mn
Sep 30, 2025 1.02 Mn
Jun 30, 2025 1.00 Mn
Mar 31, 2025 1.00 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 1.00 Mn
Jun 30, 2024 1.00 Mn
Mar 31, 2024 1.03 Mn
Dec 31, 2023 1,000,000.00
Sep 30, 2023 1.00 Mn
Jun 30, 2023 1.00 Mn
Mar 31, 2023 1.00 Mn
Dec 31, 2022 1.00 Mn
Sep 30, 2022 1.03 Mn
Jun 30, 2022 935,000.00
Mar 31, 2022 935,000.00